Assessing the efficacy of different medications in decreasing complications of transureteral lithotripsy

Phase 3

• Conditions: reteral stone.; N 21

• Registration Number: IRCT20161221031505N1
• Lead Sponsor: Tehran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 27 June 2022

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 400

Inclusion Criteria

Candidates of transureteral lithotripsy

Exclusion Criteria

Renal dysfunction, Creatinine more than 1.5 mg/dl
Previous ureteral intervention
Having Double J or ureteral catheter
age higher than 65
Weight less than 50 kg
Contraindication or allergy to medications used in project
History of using medications before intervention
Patient does not want to participate in study

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Reducing damage to the bladder. Timepoint: During TUL. Method of measurement: Observing procedure.;Reducing damage to the ureteral entrance to the bladder. Timepoint: During TUL. Method of measurement: Observing procedure.;Reducing ureteral mucosa injury. Timepoint: During transurethral lithotripsy. Method of measurement: Observing the procedure.;Reducing ureteral perforation. Timepoint: During transurethral lithotripsy. Method of measurement: Observing the procedure.;Reducing ureteral stone riching failure. Timepoint: During transurethral lithotripsy. Method of measurement: Observation the procedure.;Reducing inability to enter the ureter. Timepoint: During transurethral lithotripsy. Method of measurement: Observation during procedure.;Reducing ureteral avulsion. Timepoint: During transurethral lithotripsy. Method of measurement: Observing during procedure.;Reducing the need for a narrower ureteroscope. Timepoint: During transurethral lithotripsy. Method of measurement: Observing during procedure.